MedPath

Nifedipine

Nifedipine Extended-Release Tablets For Oral Use

Approved
Approval ID

6fafbe75-fcae-4afd-9745-02e641cefb31

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Jan 3, 2011

Manufacturers
FDA

Rebel Distributors Corp

DUNS: 118802834

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Nifedipine

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code21695-909
Application NumberANDA077899
Product Classification
M
Marketing Category
C73584
G
Generic Name
Nifedipine
Product Specifications
Route of AdministrationORAL
Effective DateFebruary 13, 2008
FDA Product Classification

INGREDIENTS (10)

NifedipineActive
Quantity: 60 mg in 1 1
Code: I9ZF7L6G2L
Classification: ACTIB
magnesium stearateInactive
Code: 70097M6I30
Classification: IACT
SILICON DIOXIDEInactive
Code: ETJ7Z6XBU4
Classification: IACT
HYPROMELLOSESInactive
Code: 3NXW29V3WO
Classification: IACT
POLYDEXTROSEInactive
Code: VH2XOU12IE
Classification: IACT
FERRIC OXIDE YELLOWInactive
Code: EX438O2MRT
Classification: IACT
lactose monohydrateInactive
Code: EWQ57Q8I5X
Classification: IACT
titanium dioxideInactive
Code: 15FIX9V2JP
Classification: IACT
POLYETHYLENE GLYCOLInactive
Code: 3WJQ0SDW1A
Classification: IACT
triacetinInactive
Code: XHX3C3X673
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Nifedipine - FDA Drug Approval Details